Gabon Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Gabon Pharmaceuticals and Healthcare Report Q3 2013 May 8th 2013, 00:00 BMI View: Increased longevity in developed markets translates into an increased demand for care for the elderly, healthcare services and medicines. However, despite increased life expectancy, in emerging markets such as Gabon communicable diseases will remain a significant health burden over the next two decades. This will continue to limit revenue-earning opportunities for companies whose product portfolios contain treatments for long-term diseases. Headline Expenditure Forecasts ? Pharmaceuticals: XAF67.65bn (US$136mn) in 2012 to XAF72.45bn (US$148mn) in 2013; +7.1% in local currency and 9.0% in US dollar terms. ? Healthcare: XAF278.54bn (US$559mn) in 2012 to XAF294.54bn (US$602mn) in 2013; +5.74% in local … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=94967. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/gabon-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions